What's new? Log in Free sign up

Filing search / Innovation Pharmaceuticals Inc. / "Employee"

Search information

Innovation Pharmaceuticals Inc.

Companies

"Employee"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

106 results

Newest first Best match first

IPIX Innovation Pharmaceuticals Inc.

Quarterly report

at June 30, 2022 Offering cost Restricted common stock award issued to employee for services Stock options issued to employee for services Stock … to employee for services Stock options issued to employee for services Net loss for the three months ended September 30, 2023 Balance at September 30

20 Nov 23

4:05pm

IPIX Innovation Pharmaceuticals Inc.

compensation - employee Stock-based compensation - consultants Depreciation and amortization expenses Total Fiscal 2023 compared to Fiscal 2022 … Conversion of 4,452 preferred stock into 69,901,865 common stocks Shares issued for exercise of stock options Shares issued to employee for services Stock

28 Sep 23

9:00am

IPIX Innovation Pharmaceuticals Inc.

Quarterly report

Capital Deficit Shares Amount Equity Balance at June 30, 2021 Offering cost Restricted stock awards of common stock issued to employee for services Stock … options issued to employee for services Stock options issued to consultants for services Conversion of 3,036 shares of preferred stock into 18,939,080

15 May 23

8:01am

IPIX Innovation Pharmaceuticals Inc.

Quarterly report

Balance at June 30, 2021 Offering cost Restricted common stock award issued to employee for services at $0.132 to $0.398 Stock options issued to employee … Accumulated Deficit Shares Amount Stockholders’ Equity Balance at June 30, 2022 Offering cost Restricted common stock award issued to employee

10 Nov 22

4:06pm

IPIX Innovation Pharmaceuticals Inc.

in employee resources or forced furlough of government employees, and refusals to accept data from clinical trials conducted in these affected geographies … expenses related to R&D department Stock-based compensation - employee Stock-based compensation - consultants Depreciation and amortization expenses Total

28 Sep 22

4:00pm

z4u jvhstt59ht4x6cc

Entry into a Material Definitive Agreement

iv6 x6vsb3qrkhq9fwtr

Quarterly report

13 May 22

4:07pm

Quarterly report

14 Feb 22

4:00pm

Quarterly report

9 Nov 21

1:44pm

27 Sep 21

4:16pm

mos64s ats9ehwdqca

Quarterly report

13 May 21

8:00am

gd2b7ew8aw2ekndjmj

Quarterly report

22 Feb 21

11:19am

Entry into a Material Definitive Agreement

Entry into a Material Definitive Agreement

dhoq0a5nlfyu6vjcbt

Quarterly report

16 Nov 20

9:00am

14 Sep 20

4:50pm

nljviyvkt5pfx9 mflmk

Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing

mjmkw9gf 02az6362fm

Shelf registration

10 Jul 20

5:08pm

Quarterly report

14 May 20

9:01am

Quarterly report

13 Feb 20

4:01pm

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.